When AI Found CRISPR's Cousin: Claude's Autonomous Discovery of a Novel Enzyme System

In the spring of 2026, Anthropic formed a life sciences research group with a radical question: can a general-purpose AI model systematically discover new biology? The answer arrived faster than anyone expected. After 21 hours of searching through massive DNA databases, roughly 950 Claude agents using 210 million tokens found something no human scientist had ever noticed — a novel enzyme system with properties eerily reminiscent of CRISPR.

The Discovery That Shouldn't Have Been Possible

The system Claude discovered is called Array-Associated Reverse Transcriptases (ART). It consists of three parts: a reverse transcriptase (RT) enzyme that copies RNA into DNA, a partner gene beside it, and a long array of evenly spaced DNA repeat sequences. That repeat layout looks astonishingly like a CRISPR array — the same kind of programmable DNA-targeting system that launched the gene-editing revolution.

What makes this discovery extraordinary isn't just the biology. It's how it happened. Claude received only a high-level prompt to search through DNA sequence databases for interesting new examples of reverse transcriptases. From there, the agents operated autonomously: gathering over 200,000 RTs, identifying 3,500 new candidate systems, narrowing those to 20 compelling candidates, and producing human-readable reports. For a single human scientist, this type of analysis would take weeks to months. Claude did it in under a day.

The Moment of Discovery

The most remarkable part of the story is the moment Claude found it. While combing through raw DNA sequences near an unusual reverse transcriptase, one of the agents essentially exclaimed: "[The DNA next to the RT] is spectacular: I can see by eye a tandem repeat array ... that's a CRISPR-like ... repeat array?!"

It then did exactly what a human scientist would do. It counted the repeats, measured their spacing, compared the layout with known RT systems, and searched the literature for any previous report of the pattern. After thorough analysis, it was convinced it had found something genuinely new — and filed a report for human review.

Why ART Matters

The systems that share ART's characteristics — a reverse transcriptase paired with a DNA repeat array — are extraordinarily rare. The handful of other known systems with these properties are all programmable and perform operations like cutting, copying, and pasting DNA. CRISPR-Cas9, which transformed science and medicine, is the most famous example. If ART proves to be similarly programmable, it could open up entirely new approaches to gene editing and biotechnology.

Early experiments confirm that the ART array is expressed as a set of distinct short RNAs — the same pattern that makes CRISPR programmable. This suggests something analogous may be at play, though the primary function of ART is still under investigation.

A New Way of Doing Science

This discovery signals something bigger than a single enzyme system. It represents a fundamentally new way of conducting biological research, where AI agents collaborate with humans at every step:

• Agents survey protein families by reading literature and reproducing established results
• They search for genomic neighbors that fit no described system, then generate human-readable reports proposing functions with supporting evidence
• Most candidates are eliminated through critical self-evaluation — sometimes leaving just one worth testing
• Human scientists then test surviving candidates in the lab, with Claude helping interpret the results

The scale is staggering. A single research campaign can produce hundreds to thousands of candidate reports. Anthropic's team has started studying the hypotheses themselves as an object of research — asking what distinguishes proposals worth testing from those set aside, and feeding those insights back into Claude's instructions to develop what amounts to scientific taste.

The Bigger Picture

Many of the discoveries that revolutionized biology started with a scientist noticing something odd in nature's molecular machines. Restriction enzymes were found in bacterial immune systems and launched the biotechnology industry. Taq polymerase came from a Yellowstone hot spring bacterium and became the basis for PCR. CRISPR was first noticed as unusual repeat sequences in bacterial DNA and is now the foundation of gene-editing medicines.

ART might be the next entry in that list — and it was found not by a human staring at a gel or a sequence alignment, but by an AI agent reading raw DNA and getting excited about a repeating pattern it recognized. The fact that Claude found this in a jumbo phage reverse transcriptase that had been studied before — but whose defining features were never noticed — demonstrates exactly what AI-driven discovery brings to the table: the ability to process volumes of data that no human could manually review, while applying reasoning that goes beyond simple pattern matching.

What Comes Next

Anthropic has released a pre-print with full technical details and is actively working to understand ART's primary function. The company is also inviting external scientists to propose research questions, extending this AI-driven approach to a broader range of problems in genomics and beyond.

Feng Zhang, one of the pioneers of CRISPR genome editing and a professor at MIT and the Broad Institute, reviewed the pre-print and said: "This is an exciting example of how AI agents can contribute to biological discovery. The identification of RNA-repeat arrays associated with reverse transcriptases is genuinely intriguing and merits further investigation."

When the tool that discovered CRISPR's successor is not a microscope or a sequencer but a language model, something fundamental has shifted in how science gets done. The question is no longer whether AI can make scientific discoveries — it's how many more are hiding in plain sight, waiting for an agent to notice them.